Global Deep Brain Stimulation Devices Market Size To Worth USD 3.44 Billion By 2033 | CAGR Of 10.22% [Yahoo! Finance]
Neuropace, Inc. (NPCE)
Company Research
Source: Yahoo! Finance
Size is Expected to Reach USD 3.44 Billion by 2033, according to a research report published by Spherical Insights & Consulting. Companies covered: Abbott, Medtronic, Neuropace Inc., Renishaw Plc., Beijing Pinchi Medical Equipment Co. Ltd, Boston Scientific Corporation, Nexstim, LivaNova Plc, Aleva Neurotherapeutics S.A., and Others Key Vendors. New York, United States , June 21, 2024 (GLOBE NEWSWIRE) -- The Global Deep Brain Stimulation Devices Market Size is to Grow from USD 1.30 Billion in 2023 to USD 3.44 Billion by 2033, at a Compound Annual Growth Rate (CAGR) of 10.22% during projected period. Get a Sample PDF Brochure: https://www.sphericalinsights.com/request-sample/4596 Deep brain stimulation (DBS) is a treatment that uses an implanted device to send an electrical current directly to specific parts of the brain. The electrodes generate electrical impulses that impact brain function, thereby curing some medical conditions. Electrical impulses can also affect cells and ch
Show less
Read more
Impact Snapshot
Event Time:
NPCE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NPCE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NPCE alerts
High impacting Neuropace, Inc. news events
Weekly update
A roundup of the hottest topics
NPCE
News
- NeuroPace, Inc.'s (NASDAQ:NPCE) top owners are private equity firms with 47% stake, while 24% is held by institutions [Yahoo! Finance]Yahoo! Finance
- NeuroPace to Participate in Two Healthcare Conferences in MayGlobeNewswire
- NeuroPace, Inc. (NASDAQ:NPCE) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- NeuroPace, Inc. (NASDAQ: NPCE) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $18.00 price target on the stock.MarketBeat
- NeuroPace Reports First Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]Yahoo! Finance
NPCE
Earnings
- 5/8/24 - In-Line
NPCE
Sec Filings
- 6/11/24 - Form 4
- 6/11/24 - Form 4
- 6/11/24 - Form 4
- NPCE's page on the SEC website